2. Choo Hean Poh, MBBS, Tomás Navarro-Rodriguez, MD, PhD, Ronnie Fass, MD Review: Treatment of Gastroesophageal Reflux Disease in the Elderly. Am J Med 2010; 123: 496–501.
3. Khajanchee YS, Urbach DR, Butler N et al. Laparoscopic antireflux surgery in the elderly. Surg Endosc 2002; 16: 25–30.
4. Cameron A.J. Barrett’s esophagus: Prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 2054–9.
5. Patti MG, Goldberg HI, Arcerito M et al. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996; 171: 182–6.
6. Pilotto A, Franceschi M, Leandro G et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 2006; 54: 1537–42.
7. Franceschi M, Di Mario F, Leandro G et al. Acid-related disorders in the elderly. Best Pract Res Clin Gastroenterol 2009; 23 (6): 839–48.
8. Fromm AL. Care of older adult populations diagnosed with Helicobacter pylori: a review of current literature. Gastroenterol Nurs 2009; 32 (6): 393–8; quiz 399–400.
9. Salles N. Is stomach spontaneously ageing? Pathophysiology of the ageing stomach. Best Pract Res Clin Gastroenterol 2009; 23 (6): 805–19.
10. Moore AR, Clinch D. Underlying mechanisms of impaired visceral pain perception in older people. J Am Geriatr Soc 2004; 52 (1): 132–6.
11. Fass R, Pulliam G, Johnson C et al. Symptom severity and esophageal chemosensitivity to acid in older and young patients with gastroesophageal reflux. Age Ageing 2000; 29: 125–30.
12. Alkema GE, Wilber KH, Frey D et al. Characteristics associated with four potential medication problems among older adults in Medicaid waiver services. Consult Pharm 2008; 23 (5): 396–403.
13. Lindblad CI, Hanlon JT, Gross CR et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006; 28 (8): 1133–43.
14. Franceschi M, Di Mario F, Leandro G et al. Acid-related disorders in the elderly. Best Pract Res Clin Gastroenterol 2009; 23 (6): 839–48.
15. Gupta M, Eisen GM. NSAIDs and the gastrointestinal tract. Curr Gastroenterol Rep 2009; 11 (5): 345–53.
16. Locke GR 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 1997; 112: 1448–56.
17. Fock KM, Talley NJ, Fass R et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008; 23 (1): 8–22.
18. Zhu H, Pace F, Sangaletti O et al. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993; 28: 235–8.
19. Räihä I, Hietanen E, Sourander L. Symptoms of gastro-esophageal reflux disease in elderly people. Age Ageing 1991; 20: 365–70.
20. Mold JW, Reed LE, Davis AB et al. Prevalence for gastro-esophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991; 86: 965–70.
21. Pilotto A, Franceschi M, Leandro G et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 2006; 54: 1537–42.
22. Bor S, Lazebnik LB, Kutapcioglu G et al. The prevalence of gastroesophageal reflux in Moscow. J Clin Gastroenterol 2006; 40 (Suppl. 4): S199.
23. Fujiwara Y, Arakawa T. Epidemiology and clinical characte-ristics of GERD in the Japanese population. J Gastroenterol 2009; 44 (6): 518–34. [Epub: 2009 Apr 14.]
24. Машарова А.А., Бордин Д.С. Особенности гастроэзофагеальной рефлюксной болезни у пожилых. Эксперим. и клин. гастроэнтерология. 2007; 4: 37–40.
25. Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol 2009; 23 (1): 3–9.
26. Vakhrushev IaM, Efremova LI, Belova EV, Romanova TP. Age-related comparative characteristics of ulcer disease course. Ter Arkh 2004; 76 (2): 15–8.
27. Лазебник Л.Б., Дроздов В.Н. Заболевания органов пищеварения у пожилых. М.: Анахарсис, 2003.
28. Juurlink DN, Gomes T, Ko DT et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180 (7): 713–8. [Epub: 2009 Jan 28.]
29.http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafet.... Public Health Advisory: Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC).
30. C:\Documents and Settings\NGMY\Local Settings\Temporary Internet Files\Content.Outlook\JQ2TOA34\Drug Safety and Availability. FDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole. mhtFDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole.
31. Bhatt DL, Cryer BL, Contant CF et al. Clopidogrel with or without Omeprazole in Coronary Artery Disease. N Engl J Med 2010; N Engl J Med 2011; 364: 681–3.
32. European Medicines Agency, 2010, Public statement 17 March 2010 EMA/174948/2010.
33. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. J Am Coll Cardiol 2010; 56: 2051–66.

М.Ф.Осипенко, Е.А.Бикбулатова 

Кафедра пропедевтики внутренних болезней НГМУ, Новосибирск